HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Devy Deliyanti Selected Research

setanaxib

1/2018Effect of NADPH oxidase 1 and 4 blockade in activated human retinal endothelial cells.
7/2015Inhibition of NOX1/4 with GKT137831: a potential novel treatment to attenuate neuroglial cell inflammation in the retina.
6/2014NADPH oxidase, NOX1, mediates vascular injury in ischemic retinopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Devy Deliyanti Research Topics

Disease

7Diabetic Retinopathy (Retinopathy, Diabetic)
01/2020 - 01/2015
6Hypoxia (Hypoxemia)
01/2020 - 06/2014
6Retinopathy of Prematurity (Retrolental Fibroplasia)
01/2020 - 03/2012
6Inflammation (Inflammations)
10/2019 - 03/2012
4Retinal Diseases
12/2020 - 07/2012
4Ganglion Cysts (Ganglion)
11/2017 - 03/2012
3Retinal Neovascularization
01/2020 - 03/2012
3Hypertension (High Blood Pressure)
10/2019 - 01/2015
3Gliosis
01/2016 - 01/2015
3Vascular System Injuries
07/2015 - 06/2014
2Vascular Diseases (Vascular Disease)
11/2018 - 01/2018
1Bronchopulmonary Dysplasia
01/2020
1Lung Injury
01/2020
1Eye Diseases (Eye Disease)
01/2020
1Respiratory Insufficiency (Respiratory Failure)
01/2020
1Demyelinating Diseases (Demyelinating Disease)
10/2019
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
10/2019
1Central Serous Chorioretinopathy
10/2019
1Experimental Diabetes Mellitus
11/2018
1Hyperoxia
01/2016
1Ischemia
07/2015
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
07/2015
1Necrosis
05/2015
1Cardiomyopathies (Cardiomyopathy)
01/2015
1Leukostasis
01/2015
1Vascular Remodeling
09/2014
1Blindness (Hysterical Blindness)
06/2014

Drug/Important Bio-Agent (IBA)

12Retinaldehyde (Retinal)IBA
01/2020 - 03/2012
6Reactive Oxygen Species (Oxygen Radicals)IBA
12/2020 - 07/2015
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 09/2014
6Messenger RNA (mRNA)IBA
01/2016 - 03/2012
5Proteins (Proteins, Gene)FDA Link
01/2020 - 09/2014
5Oxygen (Dioxygen)IBA
01/2020 - 03/2012
4NADPH Oxidases (NAD(P)H oxidase)IBA
01/2020 - 06/2014
4Interleukin-6 (Interleukin 6)IBA
01/2020 - 01/2015
4Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
07/2015 - 03/2012
3Protein Isoforms (Isoforms)IBA
01/2020 - 06/2014
3Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA
01/2020 - 03/2012
3setanaxibIBA
01/2018 - 06/2014
3AntioxidantsIBA
01/2018 - 07/2015
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2016 - 03/2012
3Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
07/2015 - 01/2015
2Type 1 Angiotensin ReceptorIBA
01/2020 - 03/2012
2Cytochrome P-450 CYP11B2 (CYP11B2)IBA
01/2020 - 03/2012
2Chemotactic FactorsIBA
01/2020 - 03/2012
2CytokinesIBA
01/2020 - 01/2015
2FadrozoleIBA
01/2020 - 03/2012
2AldosteroneIBA
10/2019 - 03/2012
2Angiotensin IIIBA
10/2019 - 11/2018
2Oxidoreductases (Dehydrogenase)IBA
07/2015 - 03/2012
1Spironolactone (Aldactone)FDA LinkGeneric
01/2020
1Tissue Inhibitor of Metalloproteinase-1IBA
01/2020
1Valsartan (Vals)FDA Link
01/2020
1InterferonsIBA
01/2020
1Superoxides (Superoxide)IBA
01/2020
1Nogo Receptor 1IBA
10/2019
1Endothelins (Endothelin)IBA
11/2018
1cyclo(Trp-Asp-Pro-Val-Leu)IBA
11/2018
1Antihypertensive Agents (Antihypertensives)IBA
11/2018
1BQ 788IBA
11/2018
12- (2- chlorophenyl)- 4- methyl- 5- (pyridin- 2- ylmethyl)- 1H- pyrazolo(4,3- c)pyridine- 3,6(2H,5H)- dioneIBA
01/2018
1Endothelin-2IBA
01/2018
1Interleukin-17 (Interleukin 17)IBA
01/2016
1Digoxin (Digitek)FDA LinkGeneric
01/2016
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2016
1SR1001IBA
01/2016
1CalciumIBA
07/2015
1ebselenIBA
07/2015
1dihydroethidiumIBA
07/2015
1Glutamate-Cysteine LigaseIBA
07/2015
1Glial Fibrillary Acidic ProteinIBA
07/2015
1Glutathione (Reduced Glutathione)IBA
07/2015
1NAD(P)H Dehydrogenase (Quinone) (Quinone Reductase)IBA
07/2015
1Heme Oxygenase-1IBA
07/2015
1B-Cell Activation Factor ReceptorIBA
07/2015
1Prorenin ReceptorIBA
05/2015
1ReninIBA
05/2015
1Interleukin-10 (Interleukin 10)IBA
05/2015
1Protective AgentsIBA
01/2015
1FT011IBA
01/2015
1ErythropoietinFDA Link
09/2014
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
03/2012

Therapy/Procedure

1Intravitreal Injections
11/2018